Talk:Bomedemstat

Medicine Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Low	This article has been rated as Low-importance on the project's importance scale.

Pharmacology Low‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Low	This article has been rated as Low-importance on the project's importance scale.

Shouldn't this article be a draft?[edit]

Especially when you look at the last paragraph, you can see that a lot of information is not even completed, see the parts below that I put in bold.

The results of this global study have been presented at the American Society of Hematology (link), the European Hematology Associate and other important forums of hematologic research. A third Imago-sponsored global clinical trial (NC....) for the treatment of essential thrombocythemia link was begun in xcxc. The results of this global study have also been presented at the American Society of Hematology (link) and the European Hematology Associate. A fourth trial begun in 2023 for the treatment of polycythemia vera link in ongoing )NC>>>). Marc Eteer (talk) 13:20, 22 May 2023 (UTC)[reply]